NFKB1 and B-cell chronic lymphocytic leukemia: Interestingly, in CLL the engagement of LAIR1 with specific mAbs blocks the constitutive and BCR-mediated Akt phosphorylation and NF-kB nuclear translocation, leading to inhibition of B cell proliferation.